Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection.
COVID-19
SARS-CoV-2
alternative splicing
causal mediation
differential expression
interferon-stimulated genes
sex differences
viral infection
Journal
Cell systems
ISSN: 2405-4720
Titre abrégé: Cell Syst
Pays: United States
ID NLM: 101656080
Informations de publication
Date de publication:
16 11 2022
16 11 2022
Historique:
received:
11
04
2022
revised:
21
07
2022
accepted:
18
10
2022
pubmed:
3
11
2022
medline:
22
11
2022
entrez:
2
11
2022
Statut:
ppublish
Résumé
Male sex is a major risk factor for SARS-CoV-2 infection severity. To understand the basis for this sex difference, we studied SARS-CoV-2 infection in a young adult cohort of United States Marine recruits. Among 2,641 male and 244 female unvaccinated and seronegative recruits studied longitudinally, SARS-CoV-2 infections occurred in 1,033 males and 137 females. We identified sex differences in symptoms, viral load, blood transcriptome, RNA splicing, and proteomic signatures. Females had higher pre-infection expression of antiviral interferon-stimulated gene (ISG) programs. Causal mediation analysis implicated ISG differences in number of symptoms, levels of ISGs, and differential splicing of CD45 lymphocyte phosphatase during infection. Our results indicate that the antiviral innate immunity set point causally contributes to sex differences in response to SARS-CoV-2 infection. A record of this paper's transparent peer review process is included in the supplemental information.
Identifiants
pubmed: 36323307
pii: S2405-4712(22)00432-X
doi: 10.1016/j.cels.2022.10.005
pmc: PMC9623453
pii:
doi:
Substances chimiques
Interferons
9008-11-1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
924-931.e4Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM071966
Pays : United States
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests C.W.G., R.A.L., S.E.L., M.A.S., M.S.T., D.L.W., and A.G.L. are military service members or government service employees. This work was prepared as part of their official duties. Title 17, US Code §105 provides that copyright protection under this title is not available for any work of the US Government. Title 17, US code §101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person’s official duties. The views expressed in the article are those of the authors and do not necessarily express the official policy and position of the US Navy, the Department of Defense, and the US Government or the institutions affiliated with the authors. O.G.T. is on the advisory board of Cell Systems.
Références
MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):283-288
pubmed: 33630816
Psychol Methods. 2010 Dec;15(4):309-34
pubmed: 20954780
Sci Signal. 2019 Oct 22;12(604):
pubmed: 31641081
Cell. 2021 Apr 1;184(7):1671-1692
pubmed: 33743212
Nat Med. 2009 Aug;15(8):955-9
pubmed: 19597505
PLoS Pathog. 2020 Apr 28;16(4):e1008520
pubmed: 32343745
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Genet. 2014 May;46(5):430-7
pubmed: 24728292
Am J Epidemiol. 2004 Feb 1;159(3):229-31
pubmed: 14742282
Virus Res. 2020 Nov;289:198171
pubmed: 32979474
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5593-601
pubmed: 25480548
BMC Public Health. 2016 Nov 29;16(1):1203
pubmed: 27899100
Nat Biotechnol. 2019 Jul;37(7):773-782
pubmed: 31061481
Cardiovasc Res. 2020 Dec 1;116(14):2197-2206
pubmed: 33063089
Nature. 2011 Apr 28;472(7344):481-5
pubmed: 21478870
PLoS Pathog. 2020 Jul 29;16(7):e1008737
pubmed: 32726355
N Engl J Med. 2020 Dec 17;383(25):2407-2416
pubmed: 33176093
Front Immunol. 2022 Apr 05;13:821730
pubmed: 35479098
Nat Genet. 2015 Jun;47(6):569-76
pubmed: 25915600
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Epidemiology. 2022 Nov 1;33(6):797-807
pubmed: 35944149
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7182-6
pubmed: 2845400
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cell. 2021 Apr 1;184(7):1895-1913.e19
pubmed: 33657410
Nat Med. 2021 Jan;27(1):28-33
pubmed: 33442016
Genome Res. 2014 Jan;24(1):14-24
pubmed: 24092820
Nucleic Acids Res. 2011 Aug;39(15):e102
pubmed: 21646338
Annu Rev Public Health. 2016;37:17-32
pubmed: 26653405
Hum Immunol. 2002 May;63(5):394-404
pubmed: 11975983
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Nucleic Acids Res. 2018 Jul 2;46(W1):W65-W70
pubmed: 29800226
Bioinformatics. 2022 Nov 25;:
pubmed: 36426870
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
Nat Rev Rheumatol. 2021 Jun;17(6):349-362
pubmed: 33907323
Hum Pathol. 2005 Jan;36(1):51-7
pubmed: 15712182
Lancet Respir Med. 2021 Jul;9(7):712-720
pubmed: 33865504
Genome Biol. 2018 Mar 23;19(1):40
pubmed: 29571299
Immunol Lett. 2004 Mar 29;92(1-2):125-34
pubmed: 15081536
Nat Rev Immunol. 2020 Jul;20(7):442-447
pubmed: 32528136
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Nat Methods. 2019 Jul;16(7):607-610
pubmed: 31249421
Nat Methods. 2019 Apr;16(4):307-310
pubmed: 30923373